American Health Packaging Recalls bupropion Hydrochloride Extended Release Tablets
American Health Packaging is recalling bupropion hydrochloride extended-release tablets due to failed stability specifications for color, dissolution, and related compounds.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition indicates that the product is not likely to cause adverse health consequences.
Plain-English summary
American Health Packaging is recalling 389 cartons of bupropion hydrochloride extended-release tablets, USP 100 mg. The affected product is identified by NDC 68084-470-01, Lot #114500, with an expiration date of 08/2013 and a repackaging date of 12/04/2011. The product was distributed nationwide.
The recall was initiated because the product failed stability specifications. Specifically, out-of-specification results were observed at the 9-month stability time point regarding color, dissolution, and related compounds.
Consumers and healthcare providers should stop using the affected product and contact their pharmacist or the recalling firm for further instructions.
The recalled product
- Product
- buPROPion Hydrochloride Extended Release Tablets, USP 100 mg, 100 count carton, 10 blister cards of 10 individually blistered and labeled tablets, Rx only, Actavis South Atlantic LLC, Packaged and Distributed by: American Health Packaging, Columbus, OH --- NDC 68084-470-01
- Manufacturer
- American Health Packaging
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 389
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- The following codes are affects by the recall: Lot #114500
- Exipration Date 08/2013
- repackaging date 12/04/2011.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · American Health Packaging
See all →- ModerateNitrofurantoin Capsules 100 mg recalled for failed dissolution specifications
FDA (Drugs) · 2022-05-25
- ModerateCyanocobalamin Injection Recalled Due to Subpotency and Assay Non-Compliance
FDA (Drugs) · 2022-05-04
- SevereOxycodone Hydrochloride Oral Solution Recall Due to Impurity Failure
FDA (Drugs) · 2022-03-16
- ModerateMetoprolol Succinate ER Tablets Recall for Failed Dissolution
FDA (Drugs) · 2022-02-02
- ModerateGlipiZIDE Extended-Release Tablets 2.5 mg Nationwide Recall
FDA (Drugs) · 2021-10-27
Same hazard · failed stability
See all →- ModeratePred Mild prednisolone eye suspension failed stability specifications
FDA (Drugs) · 2026-06-03
- HighSkin Script blemish spot treatment recalled for failing stability specifications
FDA (Drugs) · 2026-04-22
- HighZilretta Injectable Drug Recalled for Failed Stability Specifications
FDA (Drugs) · 2024-06-19
- HighSpecialty Process Labs Recalls Thyroid USP Drug Ingredient for Failed Stability
FDA (Drugs) · 2024-04-24
- SeverePrescription Birth Control Tablets Recalled for Failed Stability Testing
FDA (Drugs) · 2023-08-09